deltatrials
Unknown PHASE3 NCT00967317

Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis.

Sponsor: Laboratorios Osorio de Moraes Ltda.

Conditions Efficacy Otitis Tolerability
Interventions Auris-Sedina Otosynalar®
Updated 4 times since 2017 Last updated: Aug 25, 2009 Started: Dec 31, 2009 Primary completion: Mar 31, 2010 Completion: Apr 30, 2010

This PHASE3 trial investigates Efficacy and Otitis and is currently ongoing. Laboratorios Osorio de Moraes Ltda. leads this study, which shows 4 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  4. Jan 2017 — Jan 2021 [monthly]

    Unknown Status PHASE3

    First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Laboratorios Osorio de Moraes Ltda.
Data source: Laboratorios Osorio de Moraes Ltda.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Santo André, Brazil